...
首页> 外文期刊>Cancer epidemiology, biomarkers and prevention: A publication of the American Association for Cancer Research >GSTT1 and GSTM1 null genotypes and the risk of gastric cancer: a case-control study in a Chinese population.
【24h】

GSTT1 and GSTM1 null genotypes and the risk of gastric cancer: a case-control study in a Chinese population.

机译:GSTT1和GSTM1无效基因型与胃癌风险:在中国人群中的病例对照研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Glutathione S-transferase (GST) enzymes are involved in detoxification of many potentially carcinogenic compounds. The homozygous deletions or null genotypes of GSTT1 (theta class) and GSTM1 (mu class) genes may be associated with an increased risk of cancer. Few studies have evaluated the relationship between GSTT1, GSTM1 and the risk of gastric cancer, as well as the potential interactions between these genetic markers and other risk factors of gastric cancer in the Chinese population. We conducted a case-control study with 143 cases with gastric cancer, 166 chronic gastritis (CG) cases and 433 cancer-free population controls from Yangzhong County, China. The epidemiological data were collected by a standard questionnaire for all of the subjects, and blood samples were obtained from 91 gastric cancer cases, 146 CG cases, and 429 controls. GSTT1 and GSTM1 genotypes were assayed by the PCR method, and Helicobacter pylori infection was measured by the ELISA method. Using logistic regression model in SAS, we assessed the independent effects of GSTT1 and GSTM1 null genotypes on the risk of gastric cancer and their potential interactions with other factors. The prevalence of GSTM1 null genotype was 48% in gastric cancer cases, 60% in CG patients, and 51% in controls. The prevalence of GSTT1 null genotype was 54% in gastric cancer cases, 48% in CG patients, and 46% in controls. After controlling for age, gender, education, pack-years of smoking, alcohol drinking, body mass index, H. pylori infection, and fruit and salt intake, the adjusted odds ratio (OR) for GSTT1 and gastric cancer was 2.50 (95% confidence interval (CI), 1.01-6.22). When gastric cancer cases were compared with CG patients, the adjusted OR for GSTT1 was 2.33 (95% CI, 0.75-7.25). However, GSTT1 null genotype was not associated with the risk of CG when using population controls. No obvious association was found between GSTM1 and the risk of both gastric cancer and CG. Our results suggest that GSTT1 null genotype may be associated with an increased risk of gastric cancer in a Chinese population.
机译:谷胱甘肽S-转移酶(GST)酶参与许多潜在致癌化合物的解毒。 GSTT1(θ类)和GSTM1(μ类)基因的纯合缺失或无效基因型可能与癌症风险增加有关。很少有研究评估中国人群中GSTT1,GSTM1与胃癌风险之间的关系,以及这些遗传标志物与胃癌其他危险因素之间的潜在相互作用。我们对来自中国扬中县的143例胃癌,166例慢性胃炎(CG)病例和433例无癌人群进行了病例对照研究。通过标准调查表收集所有受试者的流行病学数据,并从91例胃癌,146例CG患者和429例对照中获取血液样本。用PCR法检测GSTT1和GSTM1基因型,用ELISA法检测幽门螺杆菌感染。使用SAS中的逻辑回归模型,我们评估了GSTT1和GSTM1无效基因型对胃癌风险及其与其他因素的潜在相互作用的独立影响。 GSTM1无效基因型的发生率在胃癌病例中为48%,在CG患者中为60%,在对照组中为51%。胃癌病例中GSTT1无效基因型的患病率为54%,CG患者的患病率为48%,对照组为46%。在控制了年龄,性别,教育程度,吸烟的包年,饮酒,体重指数,幽门螺杆菌感染以及水果和盐的摄入量之后,GSTT1和胃癌的调整后优势比(OR)为2.50(95%置信区间(CI),1.01-6.22)。当将胃癌病例与CG患者进行比较时,GSTT1的校正OR为2.33(95%CI,0.75-7.25)。但是,使用人群对照时,GSTT1无效基因型与CG的风险无关。在GSTM1与患胃癌和CG的风险之间未发现明显关联。我们的结果表明,GSTT1无效基因型可能与中国人群患胃癌的风险增加有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号